Skip to main content
. 2023 Mar 31;28:2221. doi: 10.4102/hsag.v28i0.2221

TABLE 3.

Usage of granulocyte colony-stimulating factor.

Usage n (57) Percentage (%)
G-CSF 57 100.00

  • Dose according to guideline

 32 52.14

  • Dose not according to guideline

 25 43.86

  • Duration according to guideline

 27 47.37

  • Duration not according to guideline

 30 52.63

G-CSF, granulocyte colony-stimulating factors.